IMA Clinical Research - Manhattan — New York, New York

IMA Clinical Research - Manhattan is a clinical research site located in New York, New York, United States 10036.

Crixeo Health Trust Score: 64/100 (FAIR). This profile has not yet been claimed by the site owner.

IMA Clinical Research - Manhattan has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: SARS-CoV2, COVID-19, Acute Gout Flare.

Sponsors: Vaxart, Olatec Therapeutics LLC.

Sponsor Feasibility Report

Trust Score: 64/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for IMA Clinical Research - Manhattan?

IMA Clinical Research - Manhattan has a Crixeo Trust Score of 64/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has IMA Clinical Research - Manhattan conducted?

IMA Clinical Research - Manhattan has 2 clinical trials on record, with 2 currently active. Their work covers SARS-CoV2, COVID-19, Acute Gout Flare.

Is IMA Clinical Research - Manhattan accredited by Crixeo Health?

IMA Clinical Research - Manhattan has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about IMA Clinical Research - Manhattan?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.